354 related articles for article (PubMed ID: 34428232)
21. Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India.
Kumar A; Saurabh S; Jamil S; Kumar V
BMC Infect Dis; 2020 Jan; 20(1):10. PubMed ID: 31906924
[TBL] [Abstract][Full Text] [Related]
22. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
[TBL] [Abstract][Full Text] [Related]
23. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
24. Spatial and temporal variation and hotspot detection of kala-azar disease in Vaishali district (Bihar), India.
Bhunia GS; Kesari S; Chatterjee N; Kumar V; Das P
BMC Infect Dis; 2013 Feb; 13():64. PubMed ID: 23375077
[TBL] [Abstract][Full Text] [Related]
25. A new strategy for elimination of kala-azar from rural Bihar.
Thakur CP
Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
[TBL] [Abstract][Full Text] [Related]
26. A review of non-invasive samples and tools in kala-azar diagnosis and test of cure.
Vijayakumar S; Narayan PK; Kumari S; Ranjan R; Kumar V; Kumar A; Alti D
Exp Parasitol; 2024 Apr; 259():108713. PubMed ID: 38350522
[TBL] [Abstract][Full Text] [Related]
27. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison.
Siddiqui NA; Rabidas VN; Sinha SK; Verma RB; Pandey K; Singh VP; Ranjan A; Topno RK; Lal CS; Kumar V; Sahoo GC; Sridhar S; Pandey A; Das P
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004970. PubMed ID: 27681709
[TBL] [Abstract][Full Text] [Related]
28. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
29. Time for a village-level strategy for the elimination of kala-azar (visceral leishmaniasis) in India: analysis of potential kala-azar outbreak situation in 2018.
Saurabh S
Trop Doct; 2021 Jan; 51(1):84-91. PubMed ID: 32903147
[TBL] [Abstract][Full Text] [Related]
30. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
33. Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.
Das VN; Ranjan A; Pandey K; Singh D; Verma N; Das S; Lal CS; Sinha NK; Verma RB; Siddiqui NA; Das P
Am J Trop Med Hyg; 2012 Jun; 86(6):959-61. PubMed ID: 22665600
[TBL] [Abstract][Full Text] [Related]
34. Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Dec; ():. PubMed ID: 23279744
[TBL] [Abstract][Full Text] [Related]
35. Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
Das S; Mandal R; Rabidas VN; Verma N; Pandey K; Ghosh AK; Kesari S; Kumar A; Purkait B; Lal CS; Das P
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005060. PubMed ID: 27776123
[TBL] [Abstract][Full Text] [Related]
36. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
[TBL] [Abstract][Full Text] [Related]
37. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
Joshi AB; Banjara MR; Das ML; Ghale P; Pant KR; Parajuli N; Pyakurel UR; Dahal GR; Das CL; Kroeger A; Aseffa A
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011138. PubMed ID: 36758102
[TBL] [Abstract][Full Text] [Related]
39. Visceral leishmaniasis follow-up and treatment outcomes in Tiaty East and West sub-counties, Kenya: Cure, relapse, and Post Kala-azar Dermal Leishmaniasis.
Kennedy GC; O'Brien K; Nyakundi H; Kitondo M; Biwott W; Wamai RG
PLoS One; 2024; 19(6):e0306067. PubMed ID: 38917127
[TBL] [Abstract][Full Text] [Related]
40. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
